This is a StreetInsider.com Premium Only Page

Cerevel Therapeutics Holdings (CERE) – FDA

Apr 18, 2024 06:30 AM Cerevel Therapeutics Holdings (CERE) Reports Positive Topline Results for Tavapadon

Dec 19, 2022 06:31 AM Cerevel Therapeutics (CERE) Reports Positive Results in Emraclidine Ambulatory Blood Pressure Monitoring Trial

Dec 16, 2022 05:47 AM

Feb 15, 2022 06:30 AM

Jun 29, 2021 06:31 AM

Jun 15, 2021 07:05 AM

Oct 30, 2020 07:18 AM